img

Global Ophthalmic Anti-infective Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ophthalmic Anti-infective Drug Market Insights, Forecast to 2034

Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
Market Analysis and InsightsGlobal Ophthalmic Anti-infective Drug Market
Global Ophthalmic Anti-infective Drug market is expected to reach to US$ 1523.8 million in 2024, with a positive growth of %, compared with US$ 1468.1 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ophthalmic Anti-infective Drug industry is evaluated to reach US$ 1851.5 million in 2029. The CAGR will be 3.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Ophthalmic Anti-infective Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ophthalmic Anti-infective Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Segment by Type
Eyedrops
Gels
Ointments
Other

Segment by Application


Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Ophthalmic Anti-infective Drug introduction, etc. Ophthalmic Anti-infective Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Ophthalmic Anti-infective Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Eyedrops
1.2.3 Gels
1.2.4 Ointments
1.2.5 Other
1.3 Market by Application
1.3.1 Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ophthalmic Anti-infective Drug Market Perspective (2018-2029)
2.2 Global Ophthalmic Anti-infective Drug Growth Trends by Region
2.2.1 Ophthalmic Anti-infective Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Ophthalmic Anti-infective Drug Historic Market Size by Region (2018-2024)
2.2.3 Ophthalmic Anti-infective Drug Forecasted Market Size by Region (2024-2029)
2.3 Ophthalmic Anti-infective Drug Market Dynamics
2.3.1 Ophthalmic Anti-infective Drug Industry Trends
2.3.2 Ophthalmic Anti-infective Drug Market Drivers
2.3.3 Ophthalmic Anti-infective Drug Market Challenges
2.3.4 Ophthalmic Anti-infective Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Ophthalmic Anti-infective Drug by Players
3.1.1 Global Ophthalmic Anti-infective Drug Revenue by Players (2018-2024)
3.1.2 Global Ophthalmic Anti-infective Drug Revenue Market Share by Players (2018-2024)
3.2 Global Ophthalmic Anti-infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Ophthalmic Anti-infective Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Ophthalmic Anti-infective Drug Market Concentration Ratio
3.4.1 Global Ophthalmic Anti-infective Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Anti-infective Drug Revenue in 2022
3.5 Global Key Players of Ophthalmic Anti-infective Drug Head office and Area Served
3.6 Global Key Players of Ophthalmic Anti-infective Drug, Product and Application
3.7 Global Key Players of Ophthalmic Anti-infective Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Anti-infective Drug Breakdown Data by Type
4.1 Global Ophthalmic Anti-infective Drug Historic Market Size by Type (2018-2024)
4.2 Global Ophthalmic Anti-infective Drug Forecasted Market Size by Type (2024-2029)
5 Ophthalmic Anti-infective Drug Breakdown Data by Application
5.1 Global Ophthalmic Anti-infective Drug Historic Market Size by Application (2018-2024)
5.2 Global Ophthalmic Anti-infective Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Ophthalmic Anti-infective Drug Market Size (2018-2029)
6.2 North America Ophthalmic Anti-infective Drug Market Size by Type
6.2.1 North America Ophthalmic Anti-infective Drug Market Size by Type (2018-2024)
6.2.2 North America Ophthalmic Anti-infective Drug Market Size by Type (2024-2029)
6.2.3 North America Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
6.3 North America Ophthalmic Anti-infective Drug Market Size by Application
6.3.1 North America Ophthalmic Anti-infective Drug Market Size by Application (2018-2024)
6.3.2 North America Ophthalmic Anti-infective Drug Market Size by Application (2024-2029)
6.3.3 North America Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
6.4 North America Ophthalmic Anti-infective Drug Market Size by Country
6.4.1 North America Ophthalmic Anti-infective Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Ophthalmic Anti-infective Drug Market Size by Country (2018-2024)
6.4.3 North America Ophthalmic Anti-infective Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Ophthalmic Anti-infective Drug Market Size (2018-2029)
7.2 Europe Ophthalmic Anti-infective Drug Market Size by Type
7.2.1 Europe Ophthalmic Anti-infective Drug Market Size by Type (2018-2024)
7.2.2 Europe Ophthalmic Anti-infective Drug Market Size by Type (2024-2029)
7.2.3 Europe Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
7.3 Europe Ophthalmic Anti-infective Drug Market Size by Application
7.3.1 Europe Ophthalmic Anti-infective Drug Market Size by Application (2018-2024)
7.3.2 Europe Ophthalmic Anti-infective Drug Market Size by Application (2024-2029)
7.3.3 Europe Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
7.4 Europe Ophthalmic Anti-infective Drug Market Size by Country
7.4.1 Europe Ophthalmic Anti-infective Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Ophthalmic Anti-infective Drug Market Size by Country (2018-2024)
7.4.3 Europe Ophthalmic Anti-infective Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Ophthalmic Anti-infective Drug Market Size (2018-2029)
8.2 China Ophthalmic Anti-infective Drug Market Size by Type
8.2.1 China Ophthalmic Anti-infective Drug Market Size by Type (2018-2024)
8.2.2 China Ophthalmic Anti-infective Drug Market Size by Type (2024-2029)
8.2.3 China Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
8.3 China Ophthalmic Anti-infective Drug Market Size by Application
8.3.1 China Ophthalmic Anti-infective Drug Market Size by Application (2018-2024)
8.3.2 China Ophthalmic Anti-infective Drug Market Size by Application (2024-2029)
8.3.3 China Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ophthalmic Anti-infective Drug Market Size (2018-2029)
9.2 Asia Ophthalmic Anti-infective Drug Market Size by Type
9.2.1 Asia Ophthalmic Anti-infective Drug Market Size by Type (2018-2024)
9.2.2 Asia Ophthalmic Anti-infective Drug Market Size by Type (2024-2029)
9.2.3 Asia Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
9.3 Asia Ophthalmic Anti-infective Drug Market Size by Application
9.3.1 Asia Ophthalmic Anti-infective Drug Market Size by Application (2018-2024)
9.3.2 Asia Ophthalmic Anti-infective Drug Market Size by Application (2024-2029)
9.3.3 Asia Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
9.4 Asia Ophthalmic Anti-infective Drug Market Size by Region
9.4.1 Asia Ophthalmic Anti-infective Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Ophthalmic Anti-infective Drug Market Size by Region (2018-2024)
9.4.3 Asia Ophthalmic Anti-infective Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alcon
11.1.1 Alcon Company Details
11.1.2 Alcon Business Overview
11.1.3 Alcon Ophthalmic Anti-infective Drug Introduction
11.1.4 Alcon Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.1.5 Alcon Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Ophthalmic Anti-infective Drug Introduction
11.2.4 AbbVie Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.2.5 AbbVie Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Details
11.3.2 Bausch Health Business Overview
11.3.3 Bausch Health Ophthalmic Anti-infective Drug Introduction
11.3.4 Bausch Health Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.3.5 Bausch Health Recent Developments
11.4 Santen Pharmaceutical
11.4.1 Santen Pharmaceutical Company Details
11.4.2 Santen Pharmaceutical Business Overview
11.4.3 Santen Pharmaceutical Ophthalmic Anti-infective Drug Introduction
11.4.4 Santen Pharmaceutical Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.4.5 Santen Pharmaceutical Recent Developments
11.5 Lupin Pharmaceuticals
11.5.1 Lupin Pharmaceuticals Company Details
11.5.2 Lupin Pharmaceuticals Business Overview
11.5.3 Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Introduction
11.5.4 Lupin Pharmaceuticals Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.5.5 Lupin Pharmaceuticals Recent Developments
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Ophthalmic Anti-infective Drug Introduction
11.6.4 Apotex Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.6.5 Apotex Recent Developments
11.7 Akorn
11.7.1 Akorn Company Details
11.7.2 Akorn Business Overview
11.7.3 Akorn Ophthalmic Anti-infective Drug Introduction
11.7.4 Akorn Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.7.5 Akorn Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Ophthalmic Anti-infective Drug Introduction
11.8.4 Johnson & Johnson Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.8.5 Johnson & Johnson Recent Developments
11.9 Thea pharmaceuticals
11.9.1 Thea pharmaceuticals Company Details
11.9.2 Thea pharmaceuticals Business Overview
11.9.3 Thea pharmaceuticals Ophthalmic Anti-infective Drug Introduction
11.9.4 Thea pharmaceuticals Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.9.5 Thea pharmaceuticals Recent Developments
11.10 URSAPHARM
11.10.1 URSAPHARM Company Details
11.10.2 URSAPHARM Business Overview
11.10.3 URSAPHARM Ophthalmic Anti-infective Drug Introduction
11.10.4 URSAPHARM Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.10.5 URSAPHARM Recent Developments
11.11 SIMILASAN
11.11.1 SIMILASAN Company Details
11.11.2 SIMILASAN Business Overview
11.11.3 SIMILASAN Ophthalmic Anti-infective Drug Introduction
11.11.4 SIMILASAN Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.11.5 SIMILASAN Recent Developments
11.12 Jianfeng Group
11.12.1 Jianfeng Group Company Details
11.12.2 Jianfeng Group Business Overview
11.12.3 Jianfeng Group Ophthalmic Anti-infective Drug Introduction
11.12.4 Jianfeng Group Revenue in Ophthalmic Anti-infective Drug Business (2018-2024)
11.12.5 Jianfeng Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Eyedrops
Table 3. Key Players of Gels
Table 4. Key Players of Ointments
Table 5. Key Players of Other
Table 6. Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Ophthalmic Anti-infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Ophthalmic Anti-infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Ophthalmic Anti-infective Drug Market Share by Region (2018-2024)
Table 10. Global Ophthalmic Anti-infective Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Ophthalmic Anti-infective Drug Market Share by Region (2024-2029)
Table 12. Ophthalmic Anti-infective Drug Market Trends
Table 13. Ophthalmic Anti-infective Drug Market Drivers
Table 14. Ophthalmic Anti-infective Drug Market Challenges
Table 15. Ophthalmic Anti-infective Drug Market Restraints
Table 16. Global Ophthalmic Anti-infective Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Ophthalmic Anti-infective Drug Revenue Share by Players (2018-2024)
Table 18. Global Top Ophthalmic Anti-infective Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Anti-infective Drug as of 2022)
Table 19. Global Ophthalmic Anti-infective Drug Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Ophthalmic Anti-infective Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Ophthalmic Anti-infective Drug, Headquarters and Area Served
Table 22. Global Key Players of Ophthalmic Anti-infective Drug, Product and Application
Table 23. Global Key Players of Ophthalmic Anti-infective Drug, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Ophthalmic Anti-infective Drug Revenue Market Share by Type (2018-2024)
Table 27. Global Ophthalmic Anti-infective Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Ophthalmic Anti-infective Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Ophthalmic Anti-infective Drug Revenue Share by Application (2018-2024)
Table 31. Global Ophthalmic Anti-infective Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Ophthalmic Anti-infective Drug Revenue Share by Application (2024-2029)
Table 33. North America Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Ophthalmic Anti-infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Ophthalmic Anti-infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Ophthalmic Anti-infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Ophthalmic Anti-infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Ophthalmic Anti-infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Ophthalmic Anti-infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Ophthalmic Anti-infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Ophthalmic Anti-infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Ophthalmic Anti-infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Ophthalmic Anti-infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Ophthalmic Anti-infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Ophthalmic Anti-infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Ophthalmic Anti-infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Ophthalmic Anti-infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Ophthalmic Anti-infective Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Ophthalmic Anti-infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Ophthalmic Anti-infective Drug Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 65. Alcon Company Details
Table 66. Alcon Business Overview
Table 67. Alcon Ophthalmic Anti-infective Drug Product
Table 68. Alcon Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 69. Alcon Recent Developments
Table 70. AbbVie Company Details
Table 71. AbbVie Business Overview
Table 72. AbbVie Ophthalmic Anti-infective Drug Product
Table 73. AbbVie Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 74. AbbVie Recent Developments
Table 75. Bausch Health Company Details
Table 76. Bausch Health Business Overview
Table 77. Bausch Health Ophthalmic Anti-infective Drug Product
Table 78. Bausch Health Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 79. Bausch Health Recent Developments
Table 80. Santen Pharmaceutical Company Details
Table 81. Santen Pharmaceutical Business Overview
Table 82. Santen Pharmaceutical Ophthalmic Anti-infective Drug Product
Table 83. Santen Pharmaceutical Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 84. Santen Pharmaceutical Recent Developments
Table 85. Lupin Pharmaceuticals Company Details
Table 86. Lupin Pharmaceuticals Business Overview
Table 87. Lupin Pharmaceuticals Ophthalmic Anti-infective Drug Product
Table 88. Lupin Pharmaceuticals Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 89. Lupin Pharmaceuticals Recent Developments
Table 90. Apotex Company Details
Table 91. Apotex Business Overview
Table 92. Apotex Ophthalmic Anti-infective Drug Product
Table 93. Apotex Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 94. Apotex Recent Developments
Table 95. Akorn Company Details
Table 96. Akorn Business Overview
Table 97. Akorn Ophthalmic Anti-infective Drug Product
Table 98. Akorn Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 99. Akorn Recent Developments
Table 100. Johnson & Johnson Company Details
Table 101. Johnson & Johnson Business Overview
Table 102. Johnson & Johnson Ophthalmic Anti-infective Drug Product
Table 103. Johnson & Johnson Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 104. Johnson & Johnson Recent Developments
Table 105. Thea pharmaceuticals Company Details
Table 106. Thea pharmaceuticals Business Overview
Table 107. Thea pharmaceuticals Ophthalmic Anti-infective Drug Product
Table 108. Thea pharmaceuticals Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 109. Thea pharmaceuticals Recent Developments
Table 110. URSAPHARM Company Details
Table 111. URSAPHARM Business Overview
Table 112. URSAPHARM Ophthalmic Anti-infective Drug Product
Table 113. URSAPHARM Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 114. URSAPHARM Recent Developments
Table 115. SIMILASAN Company Details
Table 116. SIMILASAN Business Overview
Table 117. SIMILASAN Ophthalmic Anti-infective Drug Product
Table 118. SIMILASAN Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 119. SIMILASAN Recent Developments
Table 120. Jianfeng Group Company Details
Table 121. Jianfeng Group Business Overview
Table 122. Jianfeng Group Ophthalmic Anti-infective Drug Product
Table 123. Jianfeng Group Revenue in Ophthalmic Anti-infective Drug Business (2018-2024) & (US$ Million)
Table 124. Jianfeng Group Recent Developments
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Ophthalmic Anti-infective Drug Market Share by Type: 2022 VS 2029
Figure 3. Eyedrops Features
Figure 4. Gels Features
Figure 5. Ointments Features
Figure 6. Other Features
Figure 7. Global Ophthalmic Anti-infective Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Ophthalmic Anti-infective Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Others Case Studies
Figure 12. Ophthalmic Anti-infective Drug Report Years Considered
Figure 13. Global Ophthalmic Anti-infective Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Ophthalmic Anti-infective Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Ophthalmic Anti-infective Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Ophthalmic Anti-infective Drug Market Share by Players in 2022
Figure 17. Global Top Ophthalmic Anti-infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Anti-infective Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Ophthalmic Anti-infective Drug Revenue in 2022
Figure 19. North America Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
Figure 21. North America Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
Figure 22. North America Ophthalmic Anti-infective Drug Market Share by Country (2018-2029)
Figure 23. United States Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Ophthalmic Anti-infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
Figure 27. Europe Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
Figure 28. Europe Ophthalmic Anti-infective Drug Market Share by Country (2018-2029)
Figure 29. Germany Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Ophthalmic Anti-infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
Figure 37. China Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
Figure 38. Asia Ophthalmic Anti-infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
Figure 40. Asia Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
Figure 41. Asia Ophthalmic Anti-infective Drug Market Share by Region (2018-2029)
Figure 42. Japan Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Ophthalmic Anti-infective Drug Market Share by Country (2018-2029)
Figure 52. Brazil Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Ophthalmic Anti-infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Alcon Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 59. AbbVie Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 60. Bausch Health Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 61. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 62. Lupin Pharmaceuticals Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 63. Apotex Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 64. Akorn Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 65. Johnson & Johnson Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 66. Thea pharmaceuticals Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 67. URSAPHARM Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 68. SIMILASAN Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 69. Jianfeng Group Revenue Growth Rate in Ophthalmic Anti-infective Drug Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries